Literature DB >> 15219380

Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1.

Iris A Halfpenny1, Derek Middleton, Yvonne A Barnett, Fionnuala Williams.   

Abstract

The polymorphic nature of the KIR3DL1/S1 gene complex has been investigated through the development of a polymerase chain reaction-sequence-specific oligonucleotide probes (PCR-SSOP) allele typing system. The KIR3DL1/S1 system was applied to a healthy group of Northern Irish individuals to establish allele frequencies within this Caucasian population. Additionally, cell line DNA and CEPH families, both from the 13th International Histocompatibility Workshop, and local families have been investigated. The generated data emphasize the complexity and highly polymorphic nature of this KIR gene complex; 11 allelic variations were identified, 2 of which are novel to this study. Use of the PCR-SSOP system has confirmed the presence of multiple copies of KIR3DL1/S1 alleles in a number of individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219380     DOI: 10.1016/j.humimm.2004.03.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  12 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

2.  KIR haplotype content at the allele level in 77 Northern Irish families.

Authors:  D Middleton; A Meenagh; P A Gourraud
Journal:  Immunogenetics       Date:  2007-01-03       Impact factor: 2.846

Review 3.  The extensive polymorphism of KIR genes.

Authors:  Derek Middleton; Faviel Gonzelez
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

4.  KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

Authors:  Jeanette E Boudreau; Fabio Giglio; Ted A Gooley; Philip A Stevenson; Jean-Benoît Le Luduec; Brian C Shaffer; Raja Rajalingam; Lihua Hou; Carolyn Katovich Hurley; Harriet Noreen; Elaine F Reed; Neng Yu; Cynthia Vierra-Green; Michael Haagenson; Mari Malkki; Effie W Petersdorf; Stephen Spellman; Katharine C Hsu
Journal:  J Clin Oncol       Date:  2017-05-18       Impact factor: 44.544

5.  An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts.

Authors:  A Thompson; A R van der Slik; F Koning; J van Bergen
Journal:  Immunogenetics       Date:  2006-10-11       Impact factor: 2.846

6.  Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.

Authors:  Sabrina B Taner; Marcelo J Pando; Allison Roberts; Jennifer Schellekens; Steven G E Marsh; Karl-Johan Malmberg; Peter Parham; Frances M Brodsky
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

7.  Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes.

Authors:  Cristina Gattazzo; Antonella Teramo; Marta Miorin; Elisa Scquizzato; Anna Cabrelle; Mirna Balsamo; Carlo Agostini; Elena Vendrame; Monica Facco; Maria Paola Albergoni; Livio Trentin; Massimo Vitale; Gianpietro Semenzato; Renato Zambello
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

8.  Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3.

Authors:  Lihui Luo; Zeying Du; Surendra K Sharma; Rebecca Cullen; Stephen Spellman; Elaine F Reed; Raja Rajalingam
Journal:  Immunogenetics       Date:  2007-07-24       Impact factor: 2.846

Review 9.  The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.

Authors:  Geraldine M O'Connor; Daniel McVicar
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

10.  Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.

Authors:  Caroline Besson; Sophie Roetynck; Fionnuala Williams; Laurent Orsi; Corinne Amiel; Catherine Lependeven; Guillemette Antoni; Olivier Hermine; Pauline Brice; Christophe Ferme; Patrice Carde; Danielle Canioni; Josette Brière; Martine Raphael; Jean-Claude Nicolas; Jacqueline Clavel; Derek Middleton; Eric Vivier; Laurent Abel
Journal:  PLoS One       Date:  2007-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.